Analysis of structure-based virtual screening studies and characterization of identified active compounds.

Analysis of structure-based virtual screening studies and characterization of identified active compounds.

Item
http://www.wikidata.org/entity/Q34212790
Molecular modeling of vasopressin receptor and in silico screening of V1b receptor antagonists.Improvements, trends, and new ideas in molecular docking: 2012-2013 in review.Computer-aided drug discovery.Drug repurposing for chronic myeloid leukemia: in silico and in vitro investigation of DrugBank database for allosteric Bcr-Abl inhibitors.CompoundProtein Interaction Prediction Within Chemogenomics: Theoretical Concepts, Practical Usage, and Future Directions.Activity Landscapes, Information Theory, and Structure - Activity Relationships.Virtual compound screening in drug discovery.In silico approach for the discovery of new PPARγ modulators among plant-derived polyphenolsDrug-Like Protein-Protein Interaction Modulators: Challenges and Opportunities for Drug Discovery and Chemical Biology.Classifiers and their Metrics Quantified.Challenges and advances in structure-based virtual screening.Reliability analysis and optimization of the consensus docking approach for the development of virtual screening studies.
P2860

Analysis of structure-based virtual screening studies and characterization of identified active compounds.

Item
http://www.wikidata.org/entity/Q34212790
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Analysis of structure-based vi ...... f identified active compounds.
@ast
Analysis of structure-based vi ...... f identified active compounds.
@en
Analysis of structure-based vi ...... f identified active compounds.
@nl
type
label
Analysis of structure-based vi ...... f identified active compounds.
@ast
Analysis of structure-based vi ...... f identified active compounds.
@en
Analysis of structure-based vi ...... f identified active compounds.
@nl
prefLabel
Analysis of structure-based vi ...... f identified active compounds.
@ast
Analysis of structure-based vi ...... f identified active compounds.
@en
Analysis of structure-based vi ...... f identified active compounds.
@nl
P1433
P1476
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Analysis of structure-based vi ...... f identified active compounds.
@en
P2860
P304
P31
P356
P433
P478
P50
P577
P698